Lisa M. Wilson
Contatto Relazioni con gli Investitori presso TYME TECHNOLOGIES, INC.
Posizioni attive di Lisa M. Wilson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Contatto Relazioni con gli Investitori | - | - |
| ETON PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | - | - |
In-Site Communications, Inc.
 In-Site Communications, Inc. Investment ManagersFinance In-Site Communications, Inc. is a private company based in New York, NY. In-Site Communications, Inc. was founded by Lisa M. Wilson. | Fondatore | 01/01/1995 | - |
| Presidente | 01/01/1995 | - |
Storia della carriera di Lisa M. Wilson
Precedenti posizioni note di Lisa M. Wilson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
BioScrip, Inc.
 BioScrip, Inc. Managed Health CareHealth Services BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. The company was founded in 1996 and is headquartered in Denver, CO. | Public Communications Contact | - | - |
| CENTENE CORPORATION | Public Communications Contact | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Public Communications Contact | 2 |
| Investor Relations Contact | 2 |
| Founder | 1 |
Settori
| Health Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CENTENE CORPORATION | Health Services |
| ETON PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
BioScrip, Inc.
BioScrip, Inc. Managed Health CareHealth Services BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. The company was founded in 1996 and is headquartered in Denver, CO. | Health Services |
In-Site Communications, Inc.
In-Site Communications, Inc. Investment ManagersFinance In-Site Communications, Inc. is a private company based in New York, NY. In-Site Communications, Inc. was founded by Lisa M. Wilson. | Finance |
- Borsa valori
- Insiders
- Lisa M. Wilson
- Esperienza